Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic Cancer Cells Through Inhibition of MUC1 Expression

Digestive Diseases and Sciences(2023)10.1007/s10620-023-07931-3Source: DataRank Database

Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic Cancer Cells Through Inhibition of MUC1 Expression is a research paper published in Digestive Diseases and Sciences (2023). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.38)OA: greenTopics (35)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Liang Wang ORCID,Yi Liu ORCID,Margarete Hafley,Lin Tan ORCID,Philip L. Lorenzi ORCID

Live enrichment

PubMed:37071246 OpenAlex:https://openalex.org/W4366240483

National Institutes of Health

Grant: RO1CA198090

National Institues of Health

Grant: P30DK056338

National Institutes of Health

Grant: 5R01CA198090-05

Integrated Signaling in Pancreatic Cancer Progression

National Institutes of Health

Grant: 5P30DK056338-18

Texas Medical Center Digestive Diseases Center

FWCI

1.38

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

greenLicense: CC BY

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12289342

publisherhttps://link.springer.com/content/pdf/10.1007/s10620-023-07931-3.pdf

publisherhttps://link.springer.com/article/10.1007/s10620-023-07931-3/fulltext.html

journalhttps://doi.org/10.1007/s10620-023-07931-3

Fields of Study

Glycosylation and Glycoproteins ResearchVitamin D Research StudiesCancer, Hypoxia, and Metabolism03 medical and health sciences0302 clinical medicine

MeSH Terms

GemcitabineAnimalsHumansPancreatic NeoplasmsReceptors, CalcitriolMucin-1Carcinoma, Pancreatic DuctalCell Line, TumorMice

Keywords

Calcitriol receptorGemcitabineCancer researchPancreatic cancerMedicineVitamin D and neurologyMUC1ParicalcitolInternal medicinePharmacologyEndocrinologyCancerCalciumPancreatic NeoplasmsMiceCell Line, TumorMucin-1AnimalsHumansReceptors, CalcitriolCarcinoma, Pancreatic Ductal

Sustainable Development Goals

SDG 0: Good health and well-being